TrialJournal of the American Heart Association2026

Long-Term Efficacy and Safety of Mavacamten in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy: Week 78 Results From the EXPLORER-CN Study.

Zhuang Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.